Alliance Pharma buy-and-build strategy working
Diclectin is entering a potential £250mln UK/European market with a differentiated product addressing an unmet need.
Company
Alliance Pharma PLC
LON:APH
Alliance Pharma PLC is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries. The company holds marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential.
156 stories · page 6 of 8
Archive
Proactive news round-up: Directa Plus, Alliance Pharma, Sound Energy...
A glance at some of the stories on the Proactive newswire today
Archive
Proactive News round-up: Obtala, Sabien Technology, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Long wait to supply Airbus is over for Hardide
Some of the largest risers and fallers in London at 3.15pm
Alliance Pharma's sales and profits double as Sinclair deal proves its worth
Diclectin is expected to receive UK regulatory approval in the third quarter
Goals Soccer scores with second half recovery
FlowGroup has selected a preferred bidder for its microcho boiler business. Also Versarien and Bahamas Petroleum.
Sinclair Pharma to pay Alliance Pharma £5mln compensation for skincare flop
A compensation payment of £4mln is now due from Sinclair on or before 30 April 2017, with a further £1mln due on or before 30 June 2018.
FTSE 100 finishes lower as Wall Street stumbles and investors mull inflation rise
Inflation jumped to 2.3% in February raising the prospect of higher interest rates
Archive
Proactive news highlights: featuring Kibo Mining, Providence Resources, Alliance Pharma and more...
Kibo Mining confident of Mbeya progress after bankable study; Providence Resources due to start Druid exploration well in June; Alliance Pharma sales double, profits in line with forecast; and more…
Alliance Pharma sales double, profits in line with forecast
The specialty pharma company said it expects sales to be £97.5mln for the 12 months ended December 31, up from £48.3mln a year earlier.
Alliance Pharma has new deputy chief executive
He is already chief commercial officer and joined the board in February 2010
Proactive News Highlights: Aminex, Amedeo Resources, Alliance Pharma, Constellation Healthcare and more...
A round up of the day's news from Proactive Investors.
Alliance Pharma boss trims holding
John Dawson still owns more than 56mln shares in the specialty pharmaceutical company, worth around £25mln
Profit and revenue double at Alliance Pharma
Alliance acquired the Sinclair Healthcare Products business in December last year, which made an immediate contribution to first half results
Alliance Pharma gains rights to pregnancy nausea drug in key EU countries
Diclectin has been used by pregnant women in Canada for over 30 years
Sinclair Pharma eyeing £2mln costs saving from staff restructuring
Sinclair Pharma plc expects to shave its annual costs by £2mln as it launched a "comprehensive" staff restructuring programme.
Proactive news highlights: Featuring Alliance Pharma, Solo Oil, DP Poland and more…
Alliance Pharma has doubled its sales after last year’s acquisition; Solo Oil gets some more good news from Horse Hill; DP Poland enjoyed a strong first half; plus much more…
Alliance Pharma confident despite 'Brexit' uncertainty
Alliance's swoop for Sinclair Healthcare Products in December helped it rack up first-half sales of £46.4mln